View in EDS HTML Full Text PDF Full Text

[The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy].

Saved in:
Bibliographic Details
Title: [The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy].
Transliterated Title: EMBARK Trial: Der Einsatz von Enzalutamid bei biochemisch rezidivierendem Prostatakarzinom nach Primärtherapie.
Authors: Shelan M; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz. mohamed.shelan@insel.ch., Mathier E; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz., Aebersold DM; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Deutschland.
Source: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2025 Jun; Vol. 201 (6), pp. 666-668. Date of Electronic Publication: 2025 Feb 21.
Publication Type: Journal Article
Journal Info: Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-099X (Electronic) Linking ISSN: 01797158 NLM ISO Abbreviation: Strahlenther Onkol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39982503
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: [The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy].
– Name: TitleTranslated
  Label: Transliterated Title
  Group: TiAlt
  Data: EMBARK Trial: Der Einsatz von Enzalutamid bei biochemisch rezidivierendem Prostatakarzinom nach Primärtherapie.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shelan+M%22">Shelan M</searchLink>; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz. mohamed.shelan@insel.ch.<br /><searchLink fieldCode="AU" term="%22Mathier+E%22">Mathier E</searchLink>; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz.<br /><searchLink fieldCode="AU" term="%22Aebersold+DM%22">Aebersold DM</searchLink>; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz.<br /><searchLink fieldCode="AU" term="%22Wiegel+T%22">Wiegel T</searchLink>; Department of Radiation Oncology, University Hospital Ulm, Ulm, Deutschland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228603469%22">Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</searchLink> [Strahlenther Onkol] 2025 Jun; Vol. 201 (6), pp. 666-668. <i>Date of Electronic Publication: </i>2025 Feb 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Urban+%26+Vogel%22">Urban & Vogel </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8603469 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1439-099X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201797158%22">01797158 </searchLink><i>NLM ISO Abbreviation: </i>Strahlenther Onkol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39982503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00066-025-02371-6
    Languages:
      – Code: ger
        Text: German
    PhysicalDescription:
      Pagination:
        StartPage: 666
    Titles:
      – TitleFull: [The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shelan M
      – PersonEntity:
          Name:
            NameFull: Mathier E
      – PersonEntity:
          Name:
            NameFull: Aebersold DM
      – PersonEntity:
          Name:
            NameFull: Wiegel T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1439-099X
          Numbering:
            – Type: volume
              Value: 201
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
              Type: main
ResultId 1